Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_ba9fccfd6f1883c207af22d35b231c91 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-505 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-711 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K36-889 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00 |
filingDate |
1995-11-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
grantDate |
1998-01-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_16a0da30d9f54ef86fa496ee6a77ecb7 |
publicationDate |
1998-01-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
RU-2102985-C1 |
titleOfInvention |
Method of hyperactive cell suppression |
abstract |
FIELD: medicine, oncology. SUBSTANCE: method involves effect of DNA acid hydrolyzate containing pyrimidine nucleotides from wheat embryos on tumor cells under conditions in vitro. EFFECT: broadened range of biomaterials showing antitumor effect. 3 cl |
priorityDate |
1995-11-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |